Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Simultaneous manifestation of pleural effusion and acute renal failure associated with dasatinib: a case report.

Kaiafa G, Kakaletsis N, Savopoulos C, Perifanis V, Giannouli A, Papadopoulos N, Zisekas S, Hatzitolios AI.

J Clin Pharm Ther. 2014 Feb;39(1):102-5. doi: 10.1111/jcpt.12107. Epub 2013 Nov 5.

PMID:
24188312
2.

Dasatinib: a review of its use in the treatment of chronic myeloid leukaemia and Philadelphia chromosome-positive acute lymphoblastic leukaemia.

McCormack PL, Keam SJ.

Drugs. 2011 Sep 10;71(13):1771-95. doi: 10.2165/11207580-000000000-00000. Review.

PMID:
21902298
4.

Dasatinib, large granular lymphocytosis, and pleural effusion: useful or adverse effect?

Paydas S.

Crit Rev Oncol Hematol. 2014 Feb;89(2):242-7. doi: 10.1016/j.critrevonc.2013.10.005. Epub 2013 Oct 12. Review.

PMID:
24210599
5.

Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion.

Eskazan AE, Eyice D, Kurt EA, Elverdi T, Yalniz FF, Salihoglu A, Ar MC, Ongoren Aydin S, Baslar Z, Ferhanoglu B, Aydin Y, Tuzuner N, Ozbek U, Soysal T.

Leuk Res. 2014 Jul;38(7):781-7. doi: 10.1016/j.leukres.2014.04.004. Epub 2014 Apr 18.

PMID:
24832371
6.

The occurrence and management of fluid retention associated with TKI therapy in CML, with a focus on dasatinib.

Masiello D, Gorospe G 3rd, Yang AS.

J Hematol Oncol. 2009 Nov 12;2:46. doi: 10.1186/1756-8722-2-46. Review.

7.

Pleural effusions due to dasatinib.

Brixey AG, Light RW.

Curr Opin Pulm Med. 2010 Jul;16(4):351-6. doi: 10.1097/MCP.0b013e328338c486. Review.

PMID:
20375898
8.

Pleural effusion in patients with chronic myelogenous leukemia treated with dasatinib after imatinib failure.

Quintás-Cardama A, Kantarjian H, O'brien S, Borthakur G, Bruzzi J, Munden R, Cortes J.

J Clin Oncol. 2007 Sep 1;25(25):3908-14.

9.

Acute renal failure under dasatinib therapy.

Ozkurt S, Temiz G, Acikalin MF, Soydan M.

Ren Fail. 2010 Jan;32(1):147-9. doi: 10.3109/08860220903391226. Review.

PMID:
20113282
10.

[Clinical profiles of 7 patients with chronic myelogenous leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia treated with dasatinib].

Hoshino T, Tahara K, Miyawaki K, Hatsumi N, Takada S, Miyawaki S, Sakura T.

Rinsho Ketsueki. 2010 Mar;51(3):181-8. Japanese.

PMID:
20379112
11.
12.

Dasatinib: an anti-tumour agent via Src inhibition.

Gnoni A, Marech I, Silvestris N, Vacca A, Lorusso V.

Curr Drug Targets. 2011 Apr;12(4):563-78. Review.

PMID:
21226671
13.

Long-term pattern of pleural effusion from chronic myeloid leukemia patients in second-line dasatinib therapy.

Kim D, Goh HG, Kim SH, Cho BS, Kim DW.

Int J Hematol. 2011 Oct;94(4):361-71. doi: 10.1007/s12185-011-0921-9. Epub 2011 Sep 8.

PMID:
21901399
14.

Dasatinib treatment for Philadelphia chromosome-positive leukemias: practical considerations.

Khoury HJ, Guilhot F, Hughes TP, Kim DW, Cortes JE.

Cancer. 2009 Apr 1;115(7):1381-94. doi: 10.1002/cncr.24155. Review.

15.

Dasatinib: BMS 354825.

[No authors listed]

Drugs R D. 2006;7(2):129-32.

PMID:
16542059
16.

Pleural/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development.

Breccia M, Alimena G.

Expert Opin Drug Saf. 2010 Sep;9(5):713-21. doi: 10.1517/14740331003742935. Review.

PMID:
20722490
17.

Dasatinib-induced pleural effusions: a lymphatic network disorder?

Goldblatt M, Huggins JT, Doelken P, Gurung P, Sahn SA.

Am J Med Sci. 2009 Nov;338(5):414-7. doi: 10.1097/MAJ.0b013e3181ae9227.

PMID:
19838099
18.

[Efficacy of dasatinib in treatment of imatinib-resistant BCR/ABL positive leukemia].

Zhu Y, Pan LQ, Qian SX, Song P, Yu H, Zhang SJ, Ge Z, Hong M, Tian T, Li JY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Jun;21(3):581-6. doi: 10.7534/j.issn.1009-2137.2013.03.009. Chinese.

PMID:
23815902
19.

New approved dasatinib regimen available for clinical use.

Snyder DS.

Expert Rev Anticancer Ther. 2009 Mar;9(3):285-92. doi: 10.1586/14737140.9.3.285. Review.

PMID:
19275507
20.
Items per page

Supplemental Content

Write to the Help Desk